Carbapenem-resistant
Enterobacteriaceae
(CRE) cause health care-associated infections worldwide, and they are of severe concern due to limited treatment options. We report an outbreak of KPC-2-producing CRE that was caused by horizontal transmission of a promiscuous plasmid across different genera of bacteria and hospitals in Germany. Eleven isolates (8
Citrobacter freundii
, 2
Klebsiella oxytoca
, and 1
Escherichia coli
) were obtained from seven critically ill patients during the six months of the outbreak in 2016. One patient developed a CRE infection while the other six patients were CRE-colonized. Three patients died in the course of the hospital stay. Six of the seven patients carried the same
C. freundii
clone; one
K. oxytoca
clone was found in two patients, and one patient carried
E. coli
and
C. freundii
. Molecular analysis confirmed the presence of a conjugative
, bla
KPC-2
-carrying 70 kb-IncN plasmid in
C. freundii
and
E. coli
and an 80 kb-IncN plasmid in
K. oxytoca.
All transconjugants harbored either the 70 or 80 kb plasmid with
bla
KPC-2,
embedded within transposon variant Tn
4401g
. Whole genome sequencing and downstream bioinformatics analyses of all plasmid sequences showed an almost perfect match when compared to a
bla
KPC-2
-carrying plasmid of a large outbreak in another German hospital two years earlier. Differences in plasmid sizes and open reading frames point to the presence of inserted mobile genetic elements. There are few outbreak reports worldwide on the transmission of
bla
KPC-2
-carrying plasmids across different bacterial genera. Our data suggest a regional and supraregional spread of
bla
KPC-2
-carrying IncN-plasmids harboring the Tn
4401g
isoform in Germany.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.